SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) Stock Price, Quote, News & History

SYMQYOTCPK
$0.5579
N/A
At close: Aug 28, 5:00 PM EST
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
8.00 / -
Day Range
- - -
52 Wk Range
0.56 - 0.99
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
26.95

Recent SymBio Pharmaceuticals Ltd News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-4.54B
Investing Cash Flow (TTM)
-82.77M
Financing Cash Flow (TTM)
2.48B
Free Cash Flow (TTM)
-4.62B
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.14B

Valuation Metrics

Enterprise Value
$30.80M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-

Company Debt

Total Debt
$832.50M
LT Debt
$0
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$977.18M
Debt to Equity
-
Issuance of Debt (TTM)
$11.19M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
8.00 / -
Day Range
- - -
52 Wk Range
0.56 - 0.99
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
26.95

About

Sector
Health Care
Industry
Pharmaceuticals
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in development of new drugs with a primary focus on the treatment of rare diseases, mainly in the areas of oncology, hematology and multiple viral infections, and conduct integrated bu...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) stock?

A

You can purchase shares of SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (OTCPK:SYMQY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) competitors?

A

There are no as such competitors for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd.

Q

What is the forecast, or price target, for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) stock?

A

There is no analysis for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd to provide a consensus price target.

Q

What is the current price for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY)?

A

The stock price for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (OTCPK: SYMQY) is $0.5579 last updated January 30, 2026 at 10:38 AM EST.

Q

Does SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) pay a dividend?

A

There are no upcoming dividends for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd.

Q

When is SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (OTCPK:SYMQY) reporting earnings?

A

SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd does not have any upcoming earnings scheduled.

Q

Is SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) going to split?

A

There is no upcoming split for SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd.

Q

What sector and industry does SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd (SYMQY) operate in?

A

SYMBIO PHARMS LTD S/ADR by Symbio Pharmaceuticals Ltd is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.